Tevogen Regains Compliance with Nasdaq Minimum Bid Price Requirement

Tevogen Regains Compliance with Nasdaq Minimum Bid Price Requirement Tevogen Regains Compliance with Nasdaq Minimum Bid Price Requirement WARREN, N.J., March 25, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN) received written notice (the “Notification Letter”) from The Nasdaq Stock Market LLC notifying the Company that it had regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5450(a)(1) for continued listing on